Safety and Efficacy of Cryobiopsy for the Diagnosis of Lymphangioleiomyomatosis Compared with Forceps Biopsy and Surgical Lung Biopsy

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2023 Dec 15

PMID 38102590

Authors

Yao Yao

Xiaobo Chen

Huanjie Chen

Zhulin Xiao

Shiyue Li

Affiliations

Soon will be listed here.

Abstract

Background: Transbronchial lung forceps biopsy (TBFB) is recommended before a surgical lung biopsy (SLB) when a definitive diagnosis of lymphangioleiomyomatosis (LAM) is required for patients without any additional confirmatory features. Transbronchial lung cryobiopsy (TBCB) has been suggested as replacement test in patients considered eligible to undergo SLB for the diagnosis of interstitial lung diseases. The efficacy and safety of TBCB were compared with that of TBFB and SLB in the diagnosis of LAM.

Methods: A retrospective analysis was conducted on 207 consecutive patients suspected with LAM in the First Affiliated Hospital of Guangzhou Medical University from 2005 to 2020.

Results: The difference in diagnostic rate of patients suspected with LAM between TBCB (20/30, 66.7%) and TBFB (70/106, 66.0%) groups was not significant (p = 0.949). One patient performed TBCB with negative pathological results could be diagnosed exclusively after SLB. LAM diagnosis was confirmed by surgical pathological findings in 3 TBFB-negative patients. More patients with minimal cystic profusion were diagnosed with LAM by TBCB (5/19, 26.3%) and SLB (11/39, 28.2%) than by TBFB (3/61, 4.9%) (TBCB vs TBFB: p = 0.04, SLB vs TBFB, p < 0.001). The difference between the severity of cystic lung disease in patients diagnosed with LAM through TBCB and SLB was not significant (p > 0.05). One pneumothorax, 8 mild bleeding and 1 moderate bleeding were observed in TBCB. One pneumothorax, 15 mild bleeding and 1 moderate bleeding occurred after TBFB.

Conclusion: Compared to TBFB, TBCB is safe and effective in diagnosing LAM at a higher diagnostic rate in patients with minimal cystic profusion.

Citing Articles

Brazilian Thoracic Association recommendations for the management of lymphangioleiomyomatosis.

Baldi B, Feitosa P, Rubin A, Amaral A, Freitas C, Costa C J Bras Pneumol. 2025; 51(1):e20240378.

PMID: 39936727 PMC: 11796567. DOI: 10.36416/1806-3756/e20240378.

Comparison Between Endobronchial-Guided Transbronchial Biopsy and Computed Tomography-Guided Transthoracic Lung Biopsy for the Diagnosis of Central Pulmonary Lesions.

Zhang C, Zhu S, Yuan Y, Dai S Clin Respir J. 2024; 18(9):e70015.

PMID: 39314190 PMC: 11420531. DOI: 10.1111/crj.70015.

References

Romagnoli M, Colby T, Berthet J, Gamez A, Mallet J, Serre I . Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases. Am J Respir Crit Care Med. 2019; 199(10):1249-1256. DOI: 10.1164/rccm.201810-1947OC. View

Ehab A, Khairy El-Badrawy M, Abdelhamed Moawad A, El-Dosouky Abo-Shehata M . Cryobiopsy versus forceps biopsy in endobronchial lesions, diagnostic yield and safety. Adv Respir Med. 2017; 85(6):301-306. DOI: 10.5603/ARM.2017.0052. View

Avila N, Chen C, Chu S, Wu M, Jones E, Neumann R . Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests. Radiology. 2000; 214(2):441-6. DOI: 10.1148/radiology.214.2.r00fe41441. View

Gupta N, Wikenheiser-Brokamp K, Zander D, Balestra R, Selvaraju A, Niehaus K . Successful diagnosis of lymphangioleiomyomatosis with transbronchial lung cryobiopsy. Lymphology. 2018; 50(3):154-157. View

Durheim M, Kim S, Gulack B, Burfeind W, Gaissert H, Kosinski A . Mortality and Respiratory Failure After Thoracoscopic Lung Biopsy for Interstitial Lung Disease. Ann Thorac Surg. 2017; 104(2):465-470. DOI: 10.1016/j.athoracsur.2017.02.013. View

McCarthy C, Gupta N, Johnson S, Yu J, McCormack F . Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. Lancet Respir Med. 2021; 9(11):1313-1327. DOI: 10.1016/S2213-2600(21)00228-9. View

Schuhmann M, Bostanci K, Bugalho A, Warth A, Schnabel P, Herth F . Endobronchial ultrasound-guided cryobiopsies in peripheral pulmonary lesions: a feasibility study. Eur Respir J. 2013; 43(1):233-9. DOI: 10.1183/09031936.00011313. View

Pajares V, Puzo C, Castillo D, Lerma E, Angeles Montero M, Ramos-Barbon D . Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology. 2014; 19(6):900-6. DOI: 10.1111/resp.12322. View

Taveira-DaSilva A, Jones A, Julien-Williams P, Yao J, Stylianou M, Moss J . Severity and outcome of cystic lung disease in women with tuberous sclerosis complex. Eur Respir J. 2014; 45(1):171-80. PMC: 8356806. DOI: 10.1183/09031936.00088314. View

10.

Harknett E, Chang W, Byrnes S, Johnson J, Lazor R, COHEN M . Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 2011; 104(11):971-9. DOI: 10.1093/qjmed/hcr116. View

11.

Koba T, Arai T, Kitaichi M, Kasai T, Hirose M, Tachibana K . Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients. Respirology. 2017; 23(3):331-338. DOI: 10.1111/resp.13190. View

12.

Gupta N, Finlay G, Kotloff R, Strange C, Wilson K, Young L . Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2017; 196(10):1337-1348. PMC: 5694834. DOI: 10.1164/rccm.201709-1965ST. View

13.

Tomassetti S, Wells A, Costabel U, Cavazza A, Colby T, Rossi G . Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2015; 193(7):745-52. DOI: 10.1164/rccm.201504-0711OC. View

14.

Hetzel J, Maldonado F, Ravaglia C, Wells A, Colby T, Tomassetti S . Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure. Respiration. 2018; 95(3):188-200. DOI: 10.1159/000484055. View

15.

Rubio E, le S, Whatley R, Boyd M . Cryobiopsy: should this be used in place of endobronchial forceps biopsies?. Biomed Res Int. 2013; 2013:730574. PMC: 3771258. DOI: 10.1155/2013/730574. View

16.

Korevaar D, Colella S, Fally M, Camuset J, Colby T, Hagmeyer L . European Respiratory Society guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases. Eur Respir J. 2022; 60(5). DOI: 10.1183/13993003.00425-2022. View

17.

Gershman E, Ridman E, Fridel L, Shtraichman O, Pertzov B, Rosengarten D . Efficacy and safety of trans-bronchial cryo in comparison with forceps biopsy in lung allograft recipients: Analysis of 402 procedures. Clin Transplant. 2018; 32(4):e13221. DOI: 10.1111/ctr.13221. View

18.

Yao J, Avila N, Dwyer A, Taveira-DaSilva A, Hathaway O, Moss J . Computer-Aided Grading of Lymphangioleiomyomatosis (LAM) using HRCT. Proc IAPR Int Conf Pattern Recogn. 2011; 2008(8-11 Dec. 2008):1-4. PMC: 3103661. DOI: 10.1109/ICPR.2008.4760991. View

19.

Babiak A, Hetzel J, Krishna G, Fritz P, Moeller P, Balli T . Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration. 2009; 78(2):203-8. DOI: 10.1159/000203987. View

20.

Hagmeyer L, Theegarten D, Treml M, Priegnitz C, Randerath W . Validation of transbronchial cryobiopsy in interstitial lung disease - interim analysis of a prospective trial and critical review of the literature. Sarcoidosis Vasc Diffuse Lung Dis. 2016; 33(1):2-9. View